About this trial
Very preterm infants in the neonatal intensive care unit (NICU) need lifesaving medical procedures which can be stressful and affect brain development. Calmer was invented to mimic key parts of parental holding (touch, heartbeat sounds and breathing motion) to help reduce stress if parents cannot be there to hold their infant. Using specialized brain scans done at full term, we will gather initial information in 22 infants born 3-4 months early to compare brain development in infants who receive Calmer at least 3 hours each day (+ regular NICU care) over 2-3 weeks with infants who have regular NICU care.
Eligibility criteria
Qualifiers
Very preterm infants admitted to the NICU at the BC Women's Hospital
Disqualifiers
Congenital anomalies;
Born small for GA (per medical admission history);
History of birthing parent substance use in pregnancy;
Ongoing infection at the time of enrollment;
Trial design
Treatments tested in this trial
- Calmer
Treatment groups
Sponsors and collaborators
University of British Columbia
Lead sponsor
BC Children's Hospital Research Institute
Collaborator